S100A9 and neoplasm: In the (murine mouse lymphoblastic lymphoma cell line (el4)), tasquinimod, through blockade of the interaction of S100A9 with its membrane receptors TLR4, could inhibit tumor growth, which was associated with reduced expression of transforming growth factor (TGFβ) [75].